Having lupus may increase your risk of food allergies. And certain foods may trigger lupus flares. Learn more.

People who are in the early stages of lupus may experience vague symptoms, such as fatigue and joint pain, while those in a ...

Yes, a dermatologist can diagnose lupus. They can also work with you to put together an effective treatment plan and monitor ...

Biogen Inc.’s stock was slightly lower Tuesday, shedding early gains made after the company and Belgian partner UCB announced positive results in a late-stage trial of a treatment for the ...

Lupus often causes a rash, which is known as a "butterfly rash," on the face. This rash can appear red in people with lighter skin tones or black, blue, brown, gray, or purple in people with ...

Oct 17 (Reuters) - Kezar Life Sciences (KZR.O), opens new tab said on Thursday it would terminate its mid-stage trial studying its experimental drug in patients with active lupus nephritis and ...

and a higher prevalence of progression to end-stage renal disease are distinguishing features of childhood-onset lupus. In contrast, a higher prevalence of pulmonary involvement, arthritis and ...

Lupus can cause a range of symptoms, including pain, rashes, fatigue, swelling in joints and fevers. It is associated with a greater risk of death from causes such as infection and cardiovascular ...

(Reuters) - Biogen and Belgian partner UCB said on Tuesday their experimental lupus treatment met the main goal of a late-stage trial in patients with the chronic disease, a surprise result after ...

The patient is a 45-year-old Caucasian male with a 5-year history of systemic lupus erythematosus (SLE). He has flat erythema that is more prominent on the upper chest, neck, and head. The rash ...

Kezar Life Sciences (KZR.O), opens new tab said on Monday it has paused a trial of its experimental drug for lupus to review safety data after four patients died in the mid-stage study.

The promising Phase 3 results come after the lupus drug failed to meet its primary goal in a Phase 2b trial. Biogen Inc. and development partner UCB shared promising late-stage trial results on ...